PRIMUCELL FIP, ρινικό εκνέφωμα, εναιώρημα για γάτες
PRIMUCELL FIP, ρινικό εκνέφωμα, εναιώρημα για γάτες
Authorised
- Feline coronavirus, strain DF2-ts, Live
Product identification
Medicine name:
PRIMUCELL FIP, ρινικό εκνέφωμα, εναιώρημα για γάτες
Active substance:
- Feline coronavirus, strain DF2-ts, Live
Target species:
-
Cat
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Feline coronavirus, strain DF2-ts, Live100000.00/cell culture infective dose 501.00Dose
Pharmaceutical form:
-
Nasal spray, suspension
Withdrawal period by route of administration:
-
Nasal use
- Cat
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Pfizer Hellas A.E.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 1417/16-01-1997/K-0101501
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
